Im Cannabis Corp Stock Beta
IMCC Stock | USD 2.59 0.02 0.77% |
Im Cannabis Corp fundamentals help investors to digest information that contributes to Im Cannabis' financial success or failures. It also enables traders to predict the movement of IMCC Stock. The fundamental analysis module provides a way to measure Im Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Im Cannabis stock.
IMCC | Beta |
Im Cannabis Corp Company Beta Analysis
Im Cannabis' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Im Cannabis Beta | 1.68 |
Most of Im Cannabis' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Im Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
IMCC Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Im Cannabis is extremely important. It helps to project a fair market value of IMCC Stock properly, considering its historical fundamentals such as Beta. Since Im Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Im Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Im Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Im Cannabis Corp has a Beta of 1.677. This is 95.0% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
IMCC Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Im Cannabis' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Im Cannabis could also be used in its relative valuation, which is a method of valuing Im Cannabis by comparing valuation metrics of similar companies.Im Cannabis is currently under evaluation in beta category among its peers.
Im Cannabis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Im Cannabis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Im Cannabis' managers, analysts, and investors.Environmental | Governance | Social |
Im Cannabis Institutional Holders
Institutional Holdings refers to the ownership stake in Im Cannabis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Im Cannabis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Im Cannabis' value.Shares | Millennium Management Llc | 2024-06-30 | 0.0 | Renaissance Technologies Corp | 2024-09-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | Advisorshares Investments, Llc | 2024-09-30 | 103.5 K | Bank Of Montreal | 2024-06-30 | 85.5 K | Bmo Capital Markets Corp. | 2024-06-30 | 85.5 K | Citadel Advisors Llc | 2024-09-30 | 14 K | Royal Bank Of Canada | 2024-06-30 | 485 | Group One Trading, Lp | 2024-06-30 | 16.0 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.0 |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Im Cannabis will likely underperform.
IMCC Fundamentals
Return On Equity | -1.12 | ||||
Return On Asset | -0.17 | ||||
Profit Margin | (0.28) % | ||||
Operating Margin | (0.20) % | ||||
Current Valuation | 18.05 M | ||||
Shares Outstanding | 3.09 M | ||||
Shares Owned By Insiders | 46.99 % | ||||
Shares Owned By Institutions | 6.12 % | ||||
Number Of Shares Shorted | 2.97 K | ||||
Price To Book | 1.89 X | ||||
Price To Sales | 0.17 X | ||||
Revenue | 48.8 M | ||||
Gross Profit | 9.16 M | ||||
EBITDA | (2.79 M) | ||||
Net Income | (10.23 M) | ||||
Cash And Equivalents | 5.86 M | ||||
Cash Per Share | 0.08 X | ||||
Total Debt | 13.78 M | ||||
Debt To Equity | 0.20 % | ||||
Current Ratio | 1.18 X | ||||
Book Value Per Share | 6.48 X | ||||
Cash Flow From Operations | (8.07 M) | ||||
Short Ratio | 0.23 X | ||||
Earnings Per Share | (4.13) X | ||||
Target Price | 8.22 | ||||
Number Of Employees | 95 | ||||
Beta | 1.68 | ||||
Market Capitalization | 8.25 M | ||||
Total Asset | 48.81 M | ||||
Retained Earnings | (249.15 M) | ||||
Working Capital | (8.54 M) | ||||
Net Asset | 48.81 M |
About Im Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Im Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Im Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Im Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:Check out Im Cannabis Piotroski F Score and Im Cannabis Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.13) | Revenue Per Share 22.335 | Quarterly Revenue Growth 0.117 | Return On Assets (0.17) | Return On Equity (1.12) |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.